✦ LIBER ✦

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

✍ Scribed by Richard Furie, William Stohl, Ellen M Ginzler…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III, randomized, placebo-control

✍ Richard Furie; Michelle Petri; Omid Zamani; Ricard Cervera; Daniel J. Wallace; D 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

Efficacy and safety of belimumab in pati

✍ Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Le 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 239 KB

A Phase I trial of B-cell depletion with

✍ R Eisenberg, D Albert, J Stansberry, D Tsai, S Kolasinski, S Khan 📂 Article 📅 2003 🏛 BioMed Central 🌐 English ⚖ 554 KB

Safety profile and clinical activity of

✍ Merrill, J. T.; Wallace, D. J.; Petri, M.; Kirou, K. A.; Yao, Y.; White, W. I.; 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 385 KB

Neutralization of interferon-α/β–inducib

✍ Yihong Yao; Laura Richman; Brandon W. Higgs; Christopher A. Morehouse; Melissa d 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 1004 KB

Efficacy and safety of secukinumab, a fu

✍ McInnes, I. B.; Sieper, J.; Braun, J.; Emery, P.; van der Heijde, D.; Isaacs, J. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 471 KB